Norepinephrine vs dopamine for severe heart failure shock
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two medicines (norepinephrine and dopamine) used to help the heart pump blood when it has severely weakened. You may qualify if your heart is not pumping well enough and you need medication support to maintain blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- Your heart is not pumping effectively, causing very low blood pressure (below 90) or requiring medicine to maintain it
- You have signs that your body is not getting enough blood flow, such as confusion, cold/clammy skin, or low urine output
- Your heart damage has been confirmed by heart catheterization (a tube placed in blood vessels) or ultrasound (echocardiogram)
- You have not received vasoactive drugs (blood pressure medicines) for more than 6 hours before enrollment
- You are not already on a mechanical heart pump or temporary life support device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that helps the heart pump blood when it is too weak to do so, even with medicine, after surgery, or while waiting for a transplant. It aims to see if it's safe and works well.
This trial studies whether doctors can safely reduce heart and blood-pressure support sooner in people with severe heart failure “shock.” It may help avoid side effects of strong medicines/devices while keeping the body’s organs well supported.
This trial tests whether setting a personalized blood pressure goal for each person in cardiogenic shock improves recovery compared to standard care. It may help if you have severe shock and can be enrolled within the first 24 hours.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This study tests whether a drug called norepinephrine can safely treat a drop in blood pressure that can happen during general anesthesia in people with chronic heart failure. It focuses on patients whose heart's pumping ability is weakened (ejection fraction 40% or less) and who are having planned surgery.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.